Abstract. The aim of this study was to conduct a search for microRNAs (miRNAs) that are significant in fetal lung develop ment to lay a foundation for further studies in the relevant fields. In this study, histological observation was performed in rats by hematoxylin and eosin (H&E) staining at three time points of fetal lung development [Embryo 21 (E21), E19 and E16, and designated as groups S1, S2 and S3, respectively]. An expression profile for fetal lung development was determined using the latest microarray technology. Furthermore, certain differentially expressed miRNAs were selected for further study by realtime PCR. In total, 202 differentially expressed miRNAs were identified. Among them, miRNA126* was selected for further study and validated by realtime PCR due to its higher expression levels in the microarrays. The results revealed that the relative expression of miRNA126* differentially increased as embyronic development increased (P<0.05), which was consistent with the microarray results.
Introduction
As one class of newly identified regulatory molecules, miRNAs are important in numerous critical cell processes, including cell proliferation, differentiation and apoptosis (13) . It has been found that ~30% of the mammalian genome is regulated by these short endogenous RNAs. As for their functions, it is widely recognized that microRNAs (miRNAs) are able to integrate with specific target mRNAs, forming close complementary structures and resulting in either mRNA degradation or inhibition of protein translation (4) . In addition, miRNAs alter gene expression mainly through their effects on the methylation of genes or by the targeting of transcription factors significant to cell physiology (5, 6) .
Over the last several years, studies have demonstrated that these tiny regulators are able to tune organ development (7) . However, few of those involved the physiological or pathological mechanisms of the lungs, particularly in mammalian fetal lung development, have been identified. The lung has a specific stable miRNA expression profile, which is conserved across mammalian species (8, 9) . Therefore, in theory it is comparable among different species. However, over the past several years, the number of expression profile studies on fetal development in mammals has been relatively small and these studies have been mostly confined to a few miRNAs, including the Let7 family (10, 11) and the miRNA1792 cluster (12, 13) . However, with the improvement of chip technology and the deepe ning understanding of the developmental mechanism, we are able to identify more of the significant miRNAs involved in fetal lung development using the latest microarrays. Therefore, in the present study, we used the miRCURY LNA™ microRNA Array (v. 16 .0) (containing >1891 probes) to determine expression profiles for fetal lung development at three key time points to identify new miRNAs. We then selected certain miRNAs for further study in order to attempt to clarify the possible mechanism involved.
Materials and methods
Rats. Healthy adult SpragueDawley rats (12 female and 12 male) were maintained in a specificpathogenfree animal facility at the Animal Center of Nanjing Medical University. In this study, 3 time points (gestational days 16, 19 and 21) representing 3 stages of fetal lung development were selected. The 3 time points were designated as groups S1 (E21), S2 (E19) and S3 (E16). For each group, 4 pregnant rats were selected according to the random contrast rule.
Identification of differentially expressed microRNAs and the possible role of miRNA-126* in Sprague-Dawley rats during fetal lung development
The pregnant rats were sacrificed with CO 2 and whole fetal lungs were immediately isolated from the fetuses. The superfluous extraneous tissues were then removed as thoroughly as possible. The procedures in this study followed the protocols approved by the Nanjing Medical University Animal Care and Use Committee.
Following isolation, a randomly selected fetal lung was retained for histological observation. Subsequently, the total RNA of the remaining lungs was isolated using TRIzol (Invitrogen Life Technologies, Carlsbad, CA, USA) and the miRNeasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. RNA quality and quantity were measured using a NanoDrop spectrophotometer (ND1000, Nanodrop Technologies, Wilmington, DE, USA) and RNA integrity was evaluated by gel electrophoresis.
Histology. The lung tissues of the 3 groups were fixed with 4% paraformaldehyde solution, embedded in paraffin and cut into 4 µm continuous sections. The sections were stained with hematoxylin and eosin (H&E) for subsequent morphological observation. H&E sections were then viewed by optical microscopy at x40 magnification to observe the structural changes of the fetal lungs in the 3 groups (S1, S2 and S3).
miRNA microarray. Following the isolation of the RNA from the fetal lungs, the miRCURY Hy3™/Hy5™ Power labeling kit (Exiqon, Vedbaek, Denmark) was used according to the manufacturer's guidelines for miRNA labeling. Each sample (1 µg) was 3'endlabeled with a Hy3™ fluorescent label using T4 RNA ligase by the following steps. RNA in 2.0 µl water was combined with 1.0 µl CIP buffer and CIP (Exiqon). The mixture was incubated for 30 min at 37˚C and then the reaction was terminated by incubation at 95˚C for 5 min. Then 3.0 µl labeling buffer, 1.5 µl fluorescent label (Hy3™), 2.0 µl DMSO and 2.0 µl labeling enzyme were added to the mixture. The labeling reaction was incubated for 1 h at 16˚C and the reaction was terminated by incubation at 65˚C for 15 min.
The Hy3™labeled miRNA samples were hybridized using the miRCURY LNA™ microRNA array system (v.16.0) (Exiqon) according to the array manual. The total 25 µl mixture of Hy3™labeled samples in 25 µl hybridization buffer was denatured for 2 min at 95˚C, incubated on ice for 2 min and then hybridized to the microarray for 1620 h at 56˚C in the 12Bay hybridization system (Nimblegen Systems, Inc., Madison, WI, USA), which provides an active mixing action and constant incubation temperature to improve hybridization uniformity and enhance the signals. Following hybridization, the slides were washed several times using a wash buffer kit (Exiqon) and dried by centrifugation for 5 min at 400 rpm. The slides were scanned using the Axon GenePix 4000B microarray scanner (Axon Instruments, Foster City, CA, USA).
The scanned images were imported into GenePix Pro 6.0 software (Axon Instruments) for grid alignment and data extraction. Replicated miRNAs were averaged and miRNAs that had intensities >50 in all samples were selected for calculation of the normalization factor. The expressed data were normalized by median normalization. Following normalization, the differentially expressed miRNAs were identified through foldchange filtering (fold change ≥1.0). Scatterplots and correlation coefficient matrices which were visualizations used to assess the variation (or reproducibility) between chips were prepared ( Fig. 1 and Table Ⅰ ). The axes of the scatterplot are the normalized signal values of the samples (ratio scale).
Quantitative real-time PCR. Total RNA was isolated from fetal lungs using the TRIzol reagent. Singlestrand cDNA was synthesized using a reverse transcription mixture that contained 1 µg total RNA, 0.3 µl rnomiRNA reverse primer (1 µM) (Table Ⅱ) dNTP mix (2.5 mM each) and 0.3 µl ribonuclease inhibitor (40 U/µl) in a 20 µl total volume. The reaction was performed at 16˚C for 30 min and at 42˚C for 40 min, followed by heat inactivation at 85˚C for 5 min. For realtime PCR, 1 µl cDNA was added to 24 µl master mix containing 2.5 µl dNTP (2.5 mM each), 2.5 µl 10X PCR buffer (Promega, Madison, WI, USA), 1 unit Taq polymerase (Promega), final concentration 0.25X SYBRGreen Ⅰ (Invitrogen) and 2 µl reverse and forward primers. cDNA was then amplified for 35 cycles using the Applied RotorGene 3000 (Corbett Research, Sydney, Australia) realtime PCR system. The primer sequences used are listed in Table Ⅲ . RT and PCR for U6 snRNA were performed in each plate as an endogenous control. The amount of PCR product was calculated from the threshold cycle (Ct). In addition, the comparative C T method was used, and the relative amount of miRNA to U6 snRNA was calculated with the equation 2 -(Ct microRNA -Ct U6)
. Statistical analysis. Data were analyzed using the SPSS 13.0 statistical package and EXCEL 2003. The realtime PCR data were evaluated by oneway ANOVA. P<0.05 was considered to indicate a statistically significant result.
Results

Histology.
In group S3 (E16), the epithelial cells had differentiated into original acinarlike structures. The structure of the interstitial tissue was extremely dense ( Fig. 2A) , while in group S2 (E19), the acinus cavities had expanded rapidly. The interstitium was arranged in cords and appeared to be thinner than in E16 (Fig. 2B) ; in group S1 (E21), more mature alveolars emerged and were arranged around the bronchioles. The interstitium was sparser than in the previous groups (Fig. 2C) .
miRNA expression profile. The 6th generation miRCURY LNA™ microRNA array (v. 16 .0) that we used covers all mouse, rat, human and virus genomes. As a result, 202 differentially expressed miRNAs from the 3 groups (S1, S2 and S3) passed the foldchange filtering (fold change ≥1.0), including 4 different types of expression patterns (S2/S3 ↑or↓ and S1/S2 ↑or↓) (Table Ⅳ) .
In addition, in view of their classic status in lung develop ment, we also selected some representative members of the rnoLet7 family and rnomiRNA1792 cluster from the differentially expressed miRNAs (Table Ⅳ) to generate line charts reflecting their expression trends during fetal lung development (Fig. 3) . Compared with these intensely investigated miRNAs, certain other miRNAs, including miRNA-126* and miRNA126, have been scarcely reported on and studied in lung development. However, both have been revealed Figure 2 . Observation of fetal lung tissue in 3 groups: (A) S1 (E21), (B) S2 (E19) and (C) S3 (E16) under an optical microscope; magnification, x40. The tissue was stained with hematoxylin and eosin (H&E). Table IV . All differentially expressed miRNAs among the 3 groups (S1, S2 and S3), including 4 expression patterns (S2/S3 ↑or↓ and S1/S2 ↑or↓).
S3-S2↑, S2-S1↑ (S2/S3>1 and S1/S2>1) a S3-S2↓,S2-S1↓ (S2/S3<1 and S1/S2<1) S3-S2↑, S2-S1↓ (S2/S3>1 and S1/S2<1) a S3-S2↓, S2-S1↑ (S2/S3<1 and S1/S2>1) Arranged from high to low according to the fold changes between S2/S3.
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to be highly enriched in mouse embryonic stem cells (15) . Additionally, more than one study has reported their significance in the vascular endothelial cells of the embryo (14, 15) . Therefore, we also prepared line charts to show the expression patterns of rnomiRNA126* and rnomiRNA126 in order to further study their possible effects in the lung development of embryos (Fig. 4) .
Real-time PCR.
Due to the exhibition of marked differential expression between rnomiRNA126* and rno-miRNA-126 in the microarray, we selected the former for analysis by realtime PCR (Fig. 4) . The results revealed that the relative expression of rnomiRNA126* determined by realtime PCR was consistent with the microarray result, revealing significant differences among the 3 groups (P<0.05; Fig. 4) .
Discussion
In the present study, we used the latest microarray technology to prepare a miRNA expression profile among three time points of fetal lung development, with 202 differentially expressed miRNAs being identified, including four different expression patterns. Among these miRNAs, a number are reported for the first time in the field of lung development, including rnomiRNA126*, rnomiRNA186*, rnomiRNA25, rno miRNA195 and rnomiRNA107 (Table Ⅳ) . In addition to these newly identified miRNAs, we also found certain classical ones associated with lung development, for example, the Let7 family and miRNA1792 cluster, and their expression patterns are shown as line charts in Fig. 3 . For several years, these two types of miRNAs have been reported and studied repeatedly due to their important roles in lung development and lung cancer. Johnson et al (10) reported that Let7 is highly expressed in the developing lungs during mouse embryogenesis. Furthermore, they demonstrated that the Let7 family directly regulates a number of key cell cycle protooncogenes, including RAS, CDC25a, CDK6 and cyclin D, and thus may further regulate cell proliferation by promoting the G1 phase into the S phase. Compared with the high expression in lung development, certain members of this family have been found to be deregulated in specific processes involved in pathological mechanisms, including pulmonary allergy, asthma and lung cancer (11) . These findings indicate that the Let7 family is essential to lung homeostasis and development.
With regard to the miRNA1792 cluster, Lu et al (12) firstly reported that its expression is high at the embryo stage and steadily declines during the development into adulthood. The authors further reported that overexpression of the miRNA1792 cluster in murine models resulted in abnormalities, in particular, terminal air sacs were lacking and were replaced by undifferentiated and highly proliferative pulmonary epithelium. By contrast, Ventura et al (13) demonstrated that mice deficient in the miRNA1792 cluster exhibited an altered phenotype characterized by hypoplasia of the lung. Subsequently, these findings were confirmed by Jevnaker et al (16) and Carraro et al (17) , respectively. In this study, we also screened these two important types of miRNA. Their expression patterns are additionally presented as line charts. Moreover, the expression trends are essentially in agreement with the former studies (Fig. 3) . The expression of the Let7 family increased gradually from group S3 (E16) to S1 (E21), while the expression of the miRNA1792 cluster manifested a downward trend as the fetal lung grew.
Compared with these intensely investigated miRNAs, certain other miRNAs, including miRNA126* and miRNA126, have rarely been discussed in relation to lung 
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development. miRNA126* and miRNA126 originate from the same domain [both mapping to intron9 of the epidermal growth factorlike domain 7 gene (Egfl7) (14) ]; the common miRNA126 (known as miRNA1263p) was firstly identified in mouse (18) and another less common miRNA126 was later revealed to be processed from the 5'half of the same premiRNA and was therefore renamed miRNA126* (also known as miRNA1265p). Although introns occupy a large portion of all genomes of eukaryotes and have been generally considered to be sequences that exist only to be removed and destroyed (19, 20) , the finding of intronic miRNA has indicated that certain excised introns may have particular functions. These include intron9 in the Egfl7 gene, which has been repeatedly demonstrated to be expressed at high levels in the vasculature associated with tissue proliferation and is abundant in specific organs, including the lungs (14, 2123) . miRNA126 and miRNA126* are processed from the same primary miRNA and located in the same intron of Egfl7, a wellknown epidermal growth factor domain gene (14) . These two miRNAs have been found to be highly enriched in endothelial cells derived from mouse embryonic stem cells (15) . Consequently, they are likely to be critical in the regulation of vascular integrity and angiogenesis (15, 24) . During the past several years, related studies on miRNA126 and miRNA126* have mostly been limited to the pathogenesis of cancers. Due to miRNA126 targeting the vascular endothelial growth factor A (VEGFA), sproutyrelated, EVH1 domaincontaining protein 1 (Spred1) and phosphatidylinositol 3kinase (PI3K), its expression has been found to be decreased in human breast cancer. By contrast, in lung cancer, miRNA126 has been shown to be upregulated to decrease the growth rate of cell lines in vitro (25) , partially through the VEGF/PI3K signaling pathway (26) . Moreover, Liu et al (25) focused on the miRNA-126 interaction with VEGF in lung cancer cells and three other cancer cell lines infected with LVmiRNA126, and revealed that miRNA 126 efficiently reduced the expression of VEGF and inhibited cell proliferation as a potential tumor suppressor. Moreover, two more studies demonstrated that the role of miRNA126 as a tumor suppressor in lung cancers may be due to its regulation of chicken tumor virus no. 10 regulator of kinase (Crk), which has been described in lung cancer and associated with increased tumor invasiveness (27, 28) . These studies suggest that miRNA126 and miRNA126* have various roles in developmental angiogenesis as well as in carcinogenesis (29) .
Compared with that of miRNA126, the role of miRNA126* is less understood, with the exception of its joint function with miRNA126 in VEGF and angiogenesis. Musiyenko et al (30) reported that the natural absence of Egfl7 leads to the absence of its intronic mRNA (miRNA126*), which indirectly promotes the invasiveness of LNCaP prostate cancer cells by allowing the expression of protein. This is one of the few studies concerning the function of miRNA126*. Until several years ago, it was assumed that one strand of the RNA duplex preferentially binds to the silencing complex during the processing of miRNA, whereas the other strand, i.e., miRNA* is degraded (31) , representing a functionally irrelevant carrier strand. However, subsequently, miRNA* species have been detected in increasing numbers with largescale small RNA sequencing efforts. In the case of miRNA-126/miRNA-126*, they have been detected with high expression levels in the same tissue (32) . In addition, the two strands of a miRNA pair are able to functionally suppress the expression of their target genes (33, 34) . Therefore, compared with common miRNA126, miRNA126* may also have its own special functions (29) .
Since miRNA-126 and miRNA-126* originate from the Egfl7 gene and share a common mRNA, in previous reports, their expression appeared always to be generally in parallel (15, 23) . Nevertheless, there are currently a few studies which report that miRNA126 expression is regulated independently of the EGFL7 protein (35) , suggesting that independent promoters may exist which regulate the expression of miRNA-126 and miRNA-126*, further indicating that they may each have respective roles in different signaling pathways and physiological mechanisms. In the present study, following the microarray screening, we found that miRNA-126 did not exhibit the same differential expression as miRNA126* in the three groups (Fig. 4) , verifying the above hypothesis.
The results of a subsequent realtime PCR assay demonstrated that miRNA-126* has significant differences in expression among the three time points (group S3 → S2 → S1) (Fig. 4) . This is the first time that the differential expression of miRNA126* has been reported in fetal lung development and, according to these results, we suggest that miRNA-126* is important in the process of fetal lung development, since its expression increases gradually as the lung develops.
As previously stated, most of the studies on these two miRNAs have been conducted in cancers. However, cells at an early stage of development are known to share several characteristics with carcinoma cells, including high and rapid proliferation. The higher tissue levels of miRNA126/126* in carcinoma cells are closely associated with their role in angiogenesis. Therefore, in the embryo, the two miRNAs may also promote lung development through the same mechanism since these two processes share the same characteristics. This hypothesis may also help to explain the role of miRNA126* in fetal lung development in the rat embryo. Furthermore, we consider that these findings are likely to lay a certain physiological foundation for studies concerning neonatal lung developmental diseases, including RDS (respiratory distress syndrome) and BPD (bronchopulmonary dysplasia). Therefore, future studies are necessary.
